Chen Haiyan, Gu Yueqing, Hu Yuzhu
Department of Biomedical Engineering, School of Life Science and Technology, China Pharmaceutical University, Nanjing, P. R. China.
J Mater Sci Mater Med. 2008 Feb;19(2):651-8. doi: 10.1007/s10856-007-3019-4. Epub 2007 Jul 10.
Two temperature sensitive drug carriers, poly (N-isopropylacrylamide-co-acrylic acid) (PNIPA-co-AA) and poly (N-isopropylacrylamide-vinyl pyrrolidone-acrylic acid) (PNIPA-VP-AA), were successfully synthesized through free radical mechanism. The diameters of PNIPA-co-AA and PNIPA-VP-AA particles can be regulated to be less than 100 nm, which were related to surfactant sodiumdodecyl sulfate and initiator ferrous ammonium sulfate, respectively. The lower critical solution temperature (LCST) of them can be manipulated to be higher than 40 degrees C, which was correlated to amount of acrylic acid (AA) that was copolymerized with NIPA. Hydrophilic anti-tumor drugs, 5-fluorouracil (5-Fu) and hydrophobic drug thalidomide were entrapped into PNIPA-co-AA and PNIPA-VP-AA, respectively. For different interaction mechanism between drug and carrier, 5-Fu was prone to be entrapped in PNIPA-co-AA with loading efficiency larger than 10% (w/w), while thalidomide was entrapped in PNIPA-VP-AA up to 80% (w/w). Fluorescein, an angiography agent, was used to evaluate the drug loading mechanism between PNIPA-VP-AA and poor water-soluble drug. In vitro drug release behavior from these two drug carriers were significantly different and showed temperature dependent, which demonstrated that PNIPA-co-AA and PNIPA-VP-AA are promising candidates for different controlled drug delivery system.
通过自由基机理成功合成了两种温度敏感型药物载体,聚(N-异丙基丙烯酰胺-共-丙烯酸)(PNIPA-co-AA)和聚(N-异丙基丙烯酰胺-乙烯基吡咯烷酮-丙烯酸)(PNIPA-VP-AA)。PNIPA-co-AA和PNIPA-VP-AA颗粒的直径可分别调节至小于100 nm,这分别与表面活性剂十二烷基硫酸钠和引发剂硫酸亚铁铵有关。它们的低临界溶液温度(LCST)可控制在高于40℃,这与与NIPA共聚的丙烯酸(AA)的量相关。亲水性抗肿瘤药物5-氟尿嘧啶(5-Fu)和疏水性药物沙利度胺分别被包裹在PNIPA-co-AA和PNIPA-VP-AA中。由于药物与载体之间的相互作用机制不同,5-Fu易于被包裹在PNIPA-co-AA中,载药效率大于10%(w/w),而沙利度胺被包裹在PNIPA-VP-AA中的载药率高达80%(w/w)。血管造影剂荧光素用于评估PNIPA-VP-AA与水溶性差的药物之间的载药机制。这两种药物载体的体外药物释放行为显著不同且表现出温度依赖性,这表明PNIPA-co-AA和PNIPA-VP-AA是不同控释给药系统的有前途的候选者。